South-Eastern Norway Regional Health Authority
Also known as: Health Region East, Norway | Helse Ost | Helse Sor-Ost | Hospital of Østfold, Kalnes | Oral Health Centre of Expertise in Eastern Norway | Ostfold Hospital Trust | Østfold Hospital Trust | Public Dental Service, Hedmark | South-Eastern Norway Regional Health Authority | South-Eastern Norway Regional Health Authority, Norway | South-Eastern Regional Health Authority | Southern-Eastern Norway Health Authorities RHF
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
Sep 15, 2025
Timeline
2000s
- Jan 1, 2007
South-Eastern Norway Regional Health Authority— Founded
Drugs by trial phase (45 distinct, 40 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Atrial Fibrillation
- Back Pain
- Breast Neoplasms
- Celiac Disease
- Clostridium Infections
- Colitis
- Colitis, Ulcerative
- Communicable Diseases
- Coronary Disease
- Crohn Disease
- Dental Caries
- Glucose Intolerance
- Glucose Metabolism Disorders
- Heart Arrest
- Hypersensitivity
- Infarction
- Infections
- Inflammatory Bowel Diseases
- Insulin Resistance
- Low Back Pain
- Lymphoma
- Lymphoma, Follicular
- Metabolic Diseases
- Myocardial Infarction
- Nausea
- Non-ST Elevated Myocardial Infarction
- Osteoarthritis
- Osteoarthritis, Hip
- Pneumonia
- Postoperative Nausea and Vomiting
- Postoperative Pain
- Psoriasis
- Purpura, Thrombocytopenic, Idiopathic
- Respiratory Tract Infections
- Sciatica
- Scleroderma, Diffuse
- Scleroderma, Systemic
- Sclerosis
- Spondylarthritis
- Stroke
- Thrombocytopenia
- Ulcer
- Urinary Bladder, Overactive
Recent trials (45)
- NCT07051915Lead sponsorPhase 3Sep 15, 2025
- NCT07040813CollaboratorPhase 3Jun 6, 2025
- NCT06853743CollaboratorPhase 2Mar 31, 2025
- NCT06653634CollaboratorPhase 4Oct 24, 2024
- NCT06440629CollaboratorPhase 4Aug 20, 2024
- NCT05732051CollaboratorPhase 2Mar 16, 2023
- NCT05717049CollaboratorPhase 2Feb 9, 2023
- NCT05614609Reponsible party - principal investigatorN/ANov 15, 2022
- NCT05306548CollaboratorPhase 4Apr 8, 2022
- NCT04817956CollaboratorPhase 2Apr 1, 2021
- NCT04703621Lead sponsorPhase 2Jan 21, 2021
- NCT04703621Overall official - principal investigatorPhase 2Jan 21, 2021
- NCT04662866CollaboratorPhase 2Dec 10, 2020
- NCT04300426CollaboratorPhase 2Apr 20, 2020
- NCT04303026Study directorPhase 3Mar 2, 2020
Details
- Founded
- Hamar, NO Jan 1, 2007
- Last known activity
- Sep 15, 2025